AMRIF

AMRIF is led by a diverse team of experts with strong track records in a variety of fields. They are united by their desire to serve the needs of their patients, clinicians and investors by developing "RESCAP" as a drug for age related diseases... We promise to do everything we can to develop RESCAP as a drug to treat age-related diseases in order to provide mankind with a natural and safe treatment to reach a high age in good health. In order to enable the treatment of as many patients as possible, we promise to do whatever is needed to increase its production capacity and to reduce the cost price of RESCAP. Further we promise to embrace any opportunity to reach this goal by working together with other experts in this field... RESCAP is based on the enzyme alkaline phosphatase and has potential in a variety of age-related diseases, like diabetes, Parkinson and frailty.

Primary location: Wageningen Netherlands